Cathie Wood's Ark Invest Increases Holdings in Nvidia and Intellia
During the week ending October 2, Cathie Wood’s Ark Invest increased its exposure to semiconductor, biotechnology, and technology stocks. The firm notably added shares of Nvidia (NVDA) and Intellia Therapeutics (NTLA), while reducing holdings in Advanced Micro Devices (AMD). This shift reflects a strategic reallocation within the tech sector. The purchase of 356,681 Nvidia shares highlights Ark Invest’s confidence in AI-driven technologies. The firm also increased its stake in biotech company Intellia Therapeutics, signaling optimism about advancements in gene editing and related therapies. Meanwhile, trimming AMD positions suggests a reassessment or rebalancing within the semiconductor space. These moves align with broader market trends favoring companies at the forefront of AI innovation and cutting-edge medical research.
Tickers: $AMD $ARKK $NTLA $NVDA
Topics: Ark Invest Biotechnology Intellia Therapeutics Nvidia Semiconductors